Our Story

GDL International was founded in 1991 as a "Generic Drug Law" company. The Drug Price Competition and Patent Term Restoration Act of 1984 is said to have given birth to the modern Generic Drug Industry in the United States. Any foreign establishment engaged in the manufacture, preparation, propagation, compounding, or processing of a device imported into the United States must identify a U.S. agent for that establishment. Hence, the birth of GDL International, a Generic Drug Law Company. GDL International was the first supplier of the API used to produce the first FDA approved generic forms of the largest pharmaceutical drug in the Veterinary Pharmaceutical Industry! That is when we declared GDL International, "The Generic Drug Leader!" We are also pioneers in the efforts to research and pursue New Drug Approvals.